Skip to content

Drug interactions

Dihydroergotamine + Pentazocine

Severity: Minor

Dihydroergotamine and Pentazocine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dihydroergotamine has serotonergic receptor activity, and pentazocine has rarely been associated with serotonin toxicity. The combination could theoretically add to serotonergic effects, although clinical evidence is scant. Dihydroergotamine is also vulnerable to CYP3A4 inhibitors, not relevant to pentazocine here.

What this interaction means in plain words

Dihydroergotamine and Pentazocine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dihydroergotamine belongs to Central Nervous System; Pentazocine belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Possible additive serotonergic effects via 5-HT receptor agonism; the mechanism is not firmly established.

What to do

No routine change is needed; counsel the patient to report agitation, tremor, sweating or fever.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dihydroergotamine and Pentazocine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dihydroergotamine with Pentazocine?

MediHelp rates the interaction as minor. Dihydroergotamine and Pentazocine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Dihydroergotamine has serotonergic receptor activity, and pentazocine has rarely been associated with serotonin toxicity. The combination could theoretically add to serotonergic effects, although clinical evidence is scant. Dihydroergotamine is also vulnerable to CYP3A4 inhibitors, not relevant to pentazocine here.

How serious is the interaction between Dihydroergotamine and Pentazocine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is needed; counsel the patient to report agitation, tremor, sweating or fever.

What other medicines interact with Pentazocine?

MediHelp also lists interactions of Pentazocine with, for example, Calcium / magnesium / potassium / sodium oxybates, Olanzapine / samidorphan, Phenelzine. The full list is on the Pentazocine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in